SS Innovations International, Inc. announced on March 28, 2025, that it has received regulatory approvals for its SSi Mantra 3 Surgical Robotic System in both the Philippines and Ukraine. These approvals mark a significant advancement in the company's international growth strategy.
In the Philippines, the registration was secured with distribution partner RBGM Medical Express Sales Inc., opening access to a healthcare market with nearly 4,000 hospitals. This move is expected to make advanced surgical robotics accessible to Filipino healthcare professionals.
The Certificate of Conformity from the Ukrainian Government was granted through a partnership with Loran Group. This approval presents an opportunity for SS Innovations to contribute to modernizing Ukraine's medical infrastructure, which is undergoing rebuilding efforts, by providing advanced, accessible robotic technology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.